NLARx Newsletter Header
NLARx News
June 4, 2008
In This Issue
Article Headline
Outrages of the Week
In the States
Fraud & Abuse
Prices & Health Costs
Generics & Patents
Conflicts of Interest
Article Headline
PBM Watch
Advertising & Marketing
Medicare
Medicaid
Safety & Clinical Trials
Confidentiality
Importation & Trade
Research Tools
Quick Links
Join Our Mailing List
NLARx Statement: Our View
NLARx Statement on California Senate Vote for Bill Allowing Sale of Personal Prescription Data More
Outrage of the Week
California Senate Caves to Drug Industry: Approves Bill Allowing Marketing Firms to Access Prescription Drug Records Without a Patient's Consent More.
In the States
WISCONSIN: Switch Saves State Millions More
CONNECTICUT: Connecticut Sues McKesson Over Price Fixing More
VERMONT: State Irked By Revised US Senate Disclosure Bill More
ARKANSAS: AG Sues AstraZeneca Over Seroquel Promotion More
MASSACHUSETTS: Number of Uninsured Reduced by Nearly Half Last Year More
PENNSYLVANIA: State Agency Seeks Control of Medicaid Managed Care Plans' Drug Benefits More
TEXAS: AG Settles Case Against Merck For False Marketing Of Vioxx More  AG Settles with Express Scripts Over Drug Switching Practices More
FLORIDA: Legislative Debate Over Generics More

State Reviews Antipsychotic Guidelines For Kids More
NEW JERSEY: Medicaid Watchdog Nominated by Corzine More
Fraud & Abuse
Bayer Unit Fined 10.3 Million Euros on Price Fixing More
Medtronic Unit Settles Fraud Case for $75 Million More
Medtronic Settlement Provides Strong Whistleblower Protections More
Department of Justice Efforts to Combat Health Care Fraud and Abuse More
First DataBank Settles AWP Case for $1 Million More

Prices & Health Care Costs
AIDS Foundation Ads Criticize Merck Pricing More
HIV Drugs Reach a Third of Patients in Need More

Generics & Patent Policy
Lawsuits, Antitrust Investigation Involving Abbott Drug Relates to Copycat Rivals More
Patent Lawsuit Settlements Delay Cheaper Drugs More
FTC Issues FY 2007 Summary of Pharmaceutical Company Settlement Agreements More
World Health Assembly Adopts Plan to Revise Patent Barriers More
Generic drug options save considerable costs More

Conflicts of Interest
Medical Student Association Grades Conflict of Interest Policies at 150 Medical Schools in US More
Most U.S. Medical Schools Do Not Adequately Limit Gifts, Payments Report Finds More

Pharma Watch
Me-Too Drugs Harder for Drug Companies to Sell More
Alnylam Deal With Takeda Embodies Two Trends More
Bayer & Glaxo Linked To Bribes In Italy More
Can Cancer Cure Pfizer? More

PBM Watch
Express Scripts Settles Drug Switching Charges For $9.3 Million More
Settlements Between PBMs, States, Indicate Need for 'Stronger Medicine' To Address Problems More
Insurers, PBMs Look At New Ways to Influence Consumers More
Advertising & Marketing
Pharma "Inappropriate Source of General Rx Info," EU Told More
E-prescribing Campaign Aims At Patients to Reach Doctors More
NEJM Analyzes Direct-To-Consumer Advertising More
Bill Moyers Interview with Melody Petersen More
At Meeting of Cancer Doctors, Small Signs Warn Minnesota Docs That Freebies Are Prohibited More
Pfizer Seeks to Counter Chantix Concerns More
The Way to a Legislator's Heart? Caterers Try More
AMA Data Mining Plan Is A Dud: Adriane Explains More
J&J Devices, Sales Reps And The Gray Market More

Medicare
CMS Part D Updates More
CMS Outreach Campaign To Enroll More Low-Income Medicare Beneficiaries in Presciption Drug Assistance Program More
Senate Finance Committee Democrats to Move Package with Medicare Advantage Plan Cuts More
Lawmakers Question Duplicative Retiree Drug Coverage More
Making Part D Work Better More
Part D: Simplifying the Program and Improving the Value of Information for Beneficiaries More

Medicaid
Judge Blocks Bush Administration Rule To Reduce Medicaid Payments to Safety Net Hospitals More
Advocates Express Concern About Rhode Island Medicaid Proposal More
Senate Approves Supplemental War Spending by Veto-Proof Majority: Bill Includes Moratorium on Medicaid Regulations More

Safety & Clinical Trials
FDA to Monitor Medicare Medical Records to Identify Potential Drug, Device Safety Problems More
Study: Health Journalists Get F in Reporting More
CSPI Protests Adding Sub-Standard Payment Guides at CMS More
New Efforts to Improve Medical Products for Patient Safety and Quality of Medical Care More
Fake Images Are Used To Support Research More
Merck Faces Vioxx Class Action Suit In Canada More
Trucking Regulators Warn on Use of Chantix More
Appellate Decisions Nullifying Awards to Vioxx Plaintiffs May Vindicate Merck's Aggressive Legal Defense More
Smoke & Mirrors: Chantix Site Hides Safety Info More
Wyeth Gets Third Approvable Letter for Osteoporosis Treatment More
2 Verdicts Against Merck Reversed More
FDA Proposes Label Changes To Provide More Info on Risks for Women Who Are Pregnant, Nursing More
Wyeth Files Brief For Levine Preemption Case More
FDA Pilot to Address Similar Drug Name Problem More
AIDS Vaccine Linked to Failed Merck Product Nears Human Testing More

Confidentiality
Health Information Technology Legislation Stalled by Privacy Concerns More
CBO Finds Health Information Technology Unlikely To Generate Significant Savings More
Coalition Pushes for E-Prescribing Legislation More

Importation & Trade
Fewer Americans Buying Drugs From Canada More
Congress Tries To Get Israel Off of US Intellectual Property Blacklist More

Opinion
A Dose of Honesty In Prescription Drug Ads More
Medicare's Much-Too-Hard Sell More
Overdue Watchman More